UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Journal of clinical oncology, 2007-08, Vol.25 (22), p.3259-3265

2007

Volltextzugriff (PDF)

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

The Lancet (British edition), 2006-09, Vol.368 (9538), p.843-854

2006

Volltextzugriff (PDF)

Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

Journal of clinical oncology, 2009-10, Vol.27 (30), p.4939-4947

2009

Volltextzugriff (PDF)

Radiation Therapy and the Geriatric Oncology Patient

Journal of clinical oncology, 2007-05, Vol.25 (14), p.1930-1935

Horiot, Jean-Claude

2007

Volltextzugriff (PDF)

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

Radiotherapy and oncology, 1997-08, Vol.44 (2), p.111-121

1997

Volltextzugriff (PDF)

Recent advances in regional treatment of breast carcinoma

Critical reviews in oncology/hematology, 2016-03, Vol.99, p.107-114

2016

Volltextzugriff (PDF)

Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

The New England journal of medicine, 2001-11, Vol.345 (19), p.1378-1387

2001

Volltextzugriff (PDF)

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

European journal of cancer (1990), 2008-11, Vol.44 (17), p.2587-2599

2008

Volltextzugriff (PDF)

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

Radiotherapy and oncology, 2009-01, Vol.90 (1), p.80-85

2009

Volltextzugriff (PDF)

Altered-fractionated radiotherapy in locally advanced head and neck cancer

Current opinion in oncology, 2012-05, Vol.24 (3), p.223-228

2012

Volltextzugriff (PDF)

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882

Radiotherapy and oncology, 2007-03, Vol.82 (3), p.265-271

2007

Volltextzugriff (PDF)

Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies

International journal of radiation oncology, biology, physics, 2000-08, Vol.48 (1), p.189-200

2000

Volltextzugriff (PDF)

Larynx preservation: What is the standard treatment?

Critical reviews in oncology/hematology, 2012-12, Vol.84, p.e97-e105

2012

Volltextzugriff (PDF)

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial

Radiotherapy and oncology, 2004-07, Vol.72 (1), p.25-33

2004

Volltextzugriff (PDF)

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial

Radiotherapy and oncology, 2000-06, Vol.55 (3), p.219-232

2000

Volltextzugriff (PDF)

At last—progress in the assessment of the adverse effects of cancer treatments

The lancet oncology, 2007-07, Vol.8 (7), p.568-570

Horiot, Jean-Claude

2007

Volltextzugriff (PDF)

EORTC Radiation Oncology Group: 50 years of continuous accomplishments

European journal of cancer supplements, 2012-03, Vol.10 (1), p.150-159

2012

Volltextzugriff (PDF)

Prophylaxis versus treatment: Is there a better way to manage radiotherapy-induced nausea and vomiting?

International journal of radiation oncology, biology, physics, 2004-11, Vol.60 (4), p.1018-1025

Horiot, Jean-Claude

2004

Volltextzugriff (PDF)

The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment

Radiotherapy and oncology, 2009-10, Vol.93 (1), p.87-93

2009

Volltextzugriff (PDF)

Preoperative radiochemotherapy in rectal cancer:: Long-term results of a phase II trial

International journal of radiation oncology, biology, physics, 2000-01, Vol.46 (2), p.323-327

2000

Volltextzugriff (PDF)

The influence of the boost in breast-conserving therapy on cosmetic outcome in the eortc “boost versus no boost” trial

International journal of radiation oncology, biology, physics, 1999-10, Vol.45 (3), p.677-685

1999

Volltextzugriff (PDF)

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC “boost versus no boost” trial

International journal of radiation oncology, biology, physics, 1999-10, Vol.45 (3), p.667-676

1999

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(69)
Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Oncology
(55)
Female
(44)
Radiology, Nuclear Medicine & Medical Imaging
(40)
Middle Aged
(37)
Radiotherapy Dosage
(31)
Adult
(30)
Radiotherapy
(30)
Aged
(28)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Male
(21)
Tumors
(19)
Breast Neoplasms - Radiotherapy
(17)
Combined Modality Therapy
(16)
Neoplasm Staging
(15)
Treatment Outcome
(15)
Breast Neoplasms - Surgery
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

Radiation Therapy and the Geriatric Oncology Patient

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

Recent advances in regional treatment of breast carcinoma

Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation

Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

Altered-fractionated radiotherapy in locally advanced head and neck cancer

Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882

Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies

Larynx preservation: What is the standard treatment?

The influence of the boost technique on local control in breast conserving treatment in the EORTC ‘boost versus no boost’ randomised trial

The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial

At last—progress in the assessment of the adverse effects of cancer treatments

EORTC Radiation Oncology Group: 50 years of continuous accomplishments

Prophylaxis versus treatment: Is there a better way to manage radiotherapy-induced nausea and vomiting?

The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment

Preoperative radiochemotherapy in rectal cancer:: Long-term results of a phase II trial

The influence of the boost in breast-conserving therapy on cosmetic outcome in the eortc “boost versus no boost” trial

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC “boost versus no boost” trial

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Suchergebnisse filtern